Rhupus Syndrome: a Unique Disease Overlapping Systemic Lupus Erythematosus and Rheumatoid Arthritis

Overview

Journal Arch Dermatol Res

Specialty Dermatology

Date 2024 Dec 14

PMID 39673628

Authors

Xu Chen

Yanju Li

Xi Chen

Yuanyuan Liu

Jing Xie

Donggeng Guo

Affiliations

Soon will be listed here.

Abstract

Background though considered to have characteristics of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) theoretically, Rhupus Syndrome (RS) owns its unique clinical features. In this retrospective cross-sectional study, we included 41 newly diagnosed Rhupus syndrome patients (NRSP). 160 new-diagnosed systemic lupus erythematosus patients (NSLEP) and 709 new-diagnosed rheumatoid arthritis patients (NRAP) were admitted as positive control groups. The clinical, serological, and radiological features among groups were compared, the disease activity of RA and SLE was evaluated, and the proportion of lymphocyte subsets in NRSPs under similar disease activity levels was explored. The initial onset age of RS patients was significantly younger than RA patients (P = 0.032), older than SLE patients (P = 0.008). 19.5% (8/41) RS patients initially presented with SLE symptom, while 12.2% RS patients presented with symptoms of both diseases. Hematopoietic dysfunction was the most prominent systemic manifestation in RS (61.0%, 25/41), only 9.8% patients experienced renal damage, and neurological disease were even rarer. Moreover, RS exhibited immunological characteristics different from NRAPs and NSLEPs, mainly manifested in decreased CD4 T cell and NK cell counts, increased ratio of CD8 + T (%) and total B cells, and decreased ratio of NK cells. RS is characterized by a higher incidence of interstitial lung disease and significant hyperglobulinemia besides the typical clinical characteristics of RA and SLE, which may be associated with a re-imbalanced lymphocyte subset. Evaluation of disease activity of RS cannot only rely on either SLEDAI-2 K or DAS28-ESR/-CRP, but more comprehensive assessment tools.

References

Antonini L, Le Mauff B, Marcelli C, Aouba A, de Boysson H . Rhupus: a systematic literature review. Autoimmun Rev. 2020; 19(9):102612. DOI: 10.1016/j.autrev.2020.102612. View

Gutta S, Das S, Kodiatte T, Vimala L . Organising pneumonia in Rhupus syndrome. BMJ Case Rep. 2019; 12(12). PMC: 6936545. DOI: 10.1136/bcr-2019-232326. View

Zengin O, Onder M, Sarica M, Turkbeyler I, Kimyon G, Demir Z . Systemic vasculitis in a patient with rhupus syndrome. Reumatismo. 2016; 67(4):161-4. DOI: 10.4081/reumatismo.2015.858. View

Wang J, Tang H, Tan C, Liu Y, Lin H, Chen Y . Diffuse lupus encephalopathy in a case of rhupus syndrome. Rheumatol Int. 2009; 30(7):961-3. DOI: 10.1007/s00296-009-1007-3. View

Sarkar S, Saha K . Bilateral acute lupus pneumonitis in a case of rhupus syndrome. Lung India. 2012; 29(3):280-2. PMC: 3424871. DOI: 10.4103/0970-2113.99119. View

Shovman O, Langevitz P, Shoenfeld Y . Rhupus; unusual presentations. Clin Rheumatol. 2015; 34(12):2041-6. DOI: 10.1007/s10067-015-2978-y. View

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

Kay J, Upchurch K . ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012; 51 Suppl 6:vi5-9. DOI: 10.1093/rheumatology/kes279. View

Vrijhoef H, Diederiks J, Spreeuwenberg C, van der Linden S . Applying low disease activity criteria using the DAS28 to assess stability in patients with rheumatoid arthritis. Ann Rheum Dis. 2003; 62(5):419-22. PMC: 1754526. DOI: 10.1136/ard.62.5.419. View

10.

Costedoat-Chalumeau N, Frances C, Pouchot J, Piette J . [The new classification criteria for systemic lupus erythematosus (SLICC)]. Rev Med Interne. 2014; 35(8):487-90. DOI: 10.1016/j.revmed.2013.11.011. View

11.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R . 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019; 78(9):1151-1159. DOI: 10.1136/annrheumdis-2018-214819. View

12.

Tani C, DAniello D, Delle Sedie A, Carli L, Cagnoni M, Possemato N . Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev. 2012; 12(4):537-41. DOI: 10.1016/j.autrev.2012.09.004. View

13.

Cavalcante E, Aikawa N, Lozano R, Lotito A, Jesus A, Silva C . Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients. Lupus. 2011; 20(9):960-4. DOI: 10.1177/0961203311400113. View

14.

Liu T, Li G, Mu R, Ye H, Li W, Li Z . Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus. 2014; 23(9):958-63. DOI: 10.1177/0961203314526439. View

15.

Castillo Dayer P, Lozano Rivas N, Martinez Ferrin J, Victoria Martinez A, Sanchez-Pedreno Guillen P, Fernandez-Cid C . Belimumab treatment in rhupus: A case report with severe skin involvement. Dermatol Ther. 2019; 32(5):e13056. DOI: 10.1111/dth.13056. View

16.

Piga M, Gabba A, Cauli A, Garau P, Vacca A, Mathieu A . Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study. Lupus. 2013; 22(6):624-8. DOI: 10.1177/0961203313482741. View

17.

Manzo C, Castagna A . Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature. Clin Pract. 2021; 11(3):404-409. PMC: 8293207. DOI: 10.3390/clinpract11030055. View

18.

van Vugt R, Derksen R, Kater L, Bijlsma J . Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis. 1998; 57(9):540-4. PMC: 1752746. DOI: 10.1136/ard.57.9.540. View

19.

Sciascia S, Roccatello D, Rossi D, Russo A, Mereuta M, Cavallo R . High-titer Anti-aquaporin-4-IgG-associated Myelitis in Rhupus Syndrome. J Rheumatol. 2012; 39(4):871-3. DOI: 10.3899/jrheum.110873. View

20.

Mastropaolo F, Bixio R . Joint erosions as potential disease subset identifier in systemic lupus erythematosus. Correspondence on: Role of ultrasound and magnetic resonance imaging in systemic lupus erythematosus erosive arthritis treatment response prediction. Clin Rheumatol. 2023; 42(9):2527-2528. DOI: 10.1007/s10067-023-06715-4. View